Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

A recent study conducted by researchers from Seattle-based University of Washington and Durham, N.C.-based Duke University found a strong association between the use of fall-risk increasing drugs and ...

Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).

Among patients with COPD who experienced an exacerbation, the risk for cardiovascular events was highest in the following 2 weeks and stayed elevated more than 1 year after, according to study results ...

Inhalers for COPD provide steroids, bronchodilators, or combination drugs. The three types differ in the mechanism by which the medication is inhaled and have different instructions for use.

Chronic obstructive pulmonary disease (COPD) can result from chronic bronchitis or emphysema. Some people may also have COPD and asthma, which can worsen both conditions. Chronic obstructive ...

2024 — A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave the way for new treatment ... Aug. 22, 2024 — Managing hard ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is needed to improve holistic patient care, according to a new editorial.

For most of us, any change to our normal existence adds a certain layer of distress. But when those moments occur and you’re living with COPD (chronic obstructive pulmonary disease), it can ...

COPD is often asymptomatic until significant damage to the lungs has occurred. When symptoms do start to appear, shortness of breath is often the first one. Patients may feel like they are hungry for ...

Regeneron Pharmaceuticals continues to show strong growth, driven by Dupixent's FDA approval for COPD and Eylea HD's ... particularly for patients at high risk for bleeding. We can roughly ...